Skip to content
ProPublica Donate
ProPublica Donate
Environment

Polluter’s Paradise

Environmental Impact in Louisiana

The petrochemical industry has grown in Louisiana, with more plants on the way, but the state’s environmental regulations haven’t kept up.

16 stories published since 2019

Air Quality Regulators in “Cancer Alley” Have Fallen Dangerously Behind

by Mark Schleifstein, The Times-Picayune | The Advocate,

Brett Duke/The Times-Picayune and The Advocate

Permit for Controversial $9 Billion Plastics Plant in “Chemical Alley” to Be Put on Hold

by Lylla Younes,

How Louisiana Lawmakers Stop Residents’ Efforts to Fight Big Oil and Gas

by Sara Sneath, The Times-Picayune | The Advocate,

How Oil Companies Avoided Environmental Accountability After 10.8 Million Gallons Spilled

by Joan Meiners, The Times-Picayune | The Advocate,

How an Environmental Regulator Became Known for Protecting Industry

by Gordon Russell, The Times-Picayune | The Advocate,

In “Cancer Alley,” Toxic Polluters Face Little Oversight From Environmental Regulators

by Gordon Russell, The Times-Picayune | The Advocate,

Chemical Companies Are Building Their Plants Overseas and Shipping Them Back In. They Still Get State Tax Breaks.

by Sara Sneath, The Times-Picayune | The Advocate,

Health Officials in “Cancer Alley” Will Study if Living Near a Controversial Chemical Plant Causes Cancer

by Gordon Russell, The Times-Picayune | The Advocate,

What Could Happen if a $9.4 Billion Chemical Plant Comes to “Cancer Alley”

by Lylla Younes,

New EPA Rules Aim to Reduce Toxic Emissions. But Many “Cancer Alley” Chemical Plants Won’t Have to Change.

by Mark Schleifstein, The Times-Picayune | The Advocate,

Even Louisiana’s Wealthier Neighborhoods Can’t Escape Toxic Air in “Cancer Alley”

by Joan Meiners, The Times-Picayune | The Advocate,

Welcome to “Cancer Alley,” Where Toxic Air Is About to Get Worse

by Tristan Baurick, The Times-Picayune | The Advocate, Lylla Younes, ProPublica, and Joan Meiners, The Times-Picayune | The Advocate,

Why Louisiana’s Air Quality Is Going From Bad to Worse, in 3 Charts

by Lylla Younes,

How We Found New Chemical Plants Are Being Built in South Louisiana’s Most Polluted Areas

by Lylla Younes and Al Shaw, ProPublica, with Michael Petroni,

I’ve Investigated Industrial Pollution for 35 Years. We’re Going Backwards.

by Mark Schleifstein, The Times-Picayune | The Advocate,

In a Notoriously Polluted Area of the Country, Massive New Chemical Plants Are Still Moving In

by Lylla Younes, Al Shaw and Claire Perlman,

What We’re Watching

During Donald Trump’s second presidency, ProPublica will focus on the areas most in need of scrutiny. Here are some of the issues our reporters will be watching — and how to get in touch with them securely.

Learn more about our reporting team. We will continue to share our areas of interest as the news develops.

Photo of Sharon Lerner
Sharon Lerner

I cover health and the environment and the agencies that govern them, including the Environmental Protection Agency.

Photo of Andy Kroll
Andy Kroll

I cover justice and the rule of law, including the Justice Department, U.S. attorneys and the courts.

Photo of Melissa Sanchez
Melissa Sanchez

I report on immigration and labor, and I am based in Chicago.

Photo of Jesse Coburn
Jesse Coburn

I cover housing and transportation, including the companies working in those fields and the regulators overseeing them.

If you don’t have a specific tip or story in mind, we could still use your help. Sign up to be a member of our federal worker source network to stay in touch.

We’re trying something new. Was it helpful?

Most Read

    The Price of Remission

    When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.

    by David Armstrong,

    DOGE Aide Who Helped Gut CFPB Was Warned About Potential Conflicts of Interest

    Before he helped fire most Consumer Financial Protection Bureau staffers, DOGE’s Gavin Kliger was warned about his investments and advised to not take any actions that could benefit him personally, according to a person familiar with the situation.

    by Jake Pearson,

    Trump’s NIH Axed Research Grants Even After a Judge Blocked the Cuts, Internal Records Show

    A lawsuit led by the Washington state attorney general offers an unprecedented view of the termination of more than 600 NIH grants, including transgender research grants threatened by Trump’s executive orders.

    by Annie Waldman,

    Life of the Mother

    Why Hospital Policies Matter in States That Ban Abortion

    Our first-of-its-kind data analysis found that a seismic split emerged in how medical institutions in Texas' two largest metro areas, Houston and Dallas, treated miscarrying patients — and in their outcomes.

    by Kavitha Surana, Lizzie Presser and Andrea Suozzo,

    Internal VA Emails Reveal How Trump Cuts Jeopardize Veterans’ Care, Including To “Life-Saving Cancer Trials”

    Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint a stark portrait of how chaotic cost cutting has already imperiled tests of treatments for cancer, opioid addiction and more.

    by Eric Umansky and Vernal Coleman,

OSZAR »